Weight Loss Medication

Obesity is a chronic health condition, and although the health consequences have been recognised for decades, safe and effective treatments have remained elusive until recently. The introduction of incretin-based medication, like Mounjaro, has revolutionised the management of obesity, offering hope for individuals who struggle to lose weight through lifestyle measures.

Weight Loss Medication

Obesity is a chronic health condition, and although the health consequences have been recognised for decades, safe and effective treatments have remained elusive until recently. The introduction of incretin-based medication, like Mounjaro, has revolutionised the management of obesity, offering hope for individuals who struggle to lose weight through lifestyle measures.

Weight Loss Medication

Obesity is a chronic health condition, and although the health consequences have been recognised for decades, safe and effective treatments have remained elusive until recently. The introduction of incretin-based medication, like Mounjaro, has revolutionised the management of obesity, offering hope for individuals who struggle to lose weight through lifestyle measures.

Weight Loss Medication

Obesity is a chronic health condition, and although the health consequences have been recognised for decades, safe and effective treatments have remained elusive until recently. The introduction of incretin-based medication, like Mounjaro, has revolutionised the management of obesity, offering hope for individuals who struggle to lose weight through lifestyle measures.

Weight Loss Medication

Understanding Weight Loss Medication

Mounjaro and Foundayo are weight-loss medications that help regulate appetite, support fat burning, and manage blood sugar. It is suitable for people with obesity, certain health conditions, or Type 2 diabetes. Mounjaro can produce significant weight loss and may also benefit heart and kidney health. It may cause side effects and is not suitable for everyone.

What is Mounjaro?

Mounjaro (tirzepatide) is a prescription medication that combines two hormones, GLP-1 and GIP, which both play essential roles in regulating appetite and immune function.

Who is it for?

  • Patients with obesity or a BMI in the overweight range with a health complication.

  • Patients with Type 2 diabetes.

How does Mounjaro work?

  • It slows the rate at which food leaves the stomach, helping you feel full for a longer period.

  • It reduces 'food noise' or distractions related to hunger.

  • It encourages the body to utilise fat as a fuel source.

How is it taken?

Mounjaro is administered as a weekly injection under the skin, typically in the abdomen, upper leg, or upper arm.

What are the benefits?

  • It is highly effective for weight loss, with many patients losing over 25% of their body weight.

  • It causes less muscle loss compared to fasting diets (30% loss versus 50-66% loss).

  • It has been shown to improve cardiovascular health and protect against kidney disease.

What are the common side effects?

Like all medications, Mounjaro may cause side effects.

Common side effects can include:

  • Nausea

  • Diarrhoea

  • Vomiting

  • Constipation

  • Abdominal pain

  • Headache

Uncommon side effects may include:

  • Acute pancreatitis (recent studies have not shown an increased risk).

  • Gallstones (which can occur with other medications that induce rapid weight loss).

Who shouldn't take it?

Like all medications, Mounjaro may cause side effects.

  • A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

  • A diagnosis of gastroparesis.

  • Anyone with a history of an eating disorder.

Weight Loss Medication

Understanding Weight Loss Medication

Mounjaro and Foundayo are weight-loss medications that help regulate appetite, support fat burning, and manage blood sugar. It is suitable for people with obesity, certain health conditions, or Type 2 diabetes. Mounjaro can produce significant weight loss and may also benefit heart and kidney health. It may cause side effects and is not suitable for everyone.

What is Mounjaro?

Mounjaro (tirzepatide) is a prescription medication that combines two hormones, GLP-1 and GIP, which both play essential roles in regulating appetite and immune function.

Who is it for?

  • Patients with obesity or a BMI in the overweight range with a health complication.

  • Patients with Type 2 diabetes.

How does Mounjaro work?

  • It slows the rate at which food leaves the stomach, helping you feel full for a longer period.

  • It reduces 'food noise' or distractions related to hunger.

  • It encourages the body to utilise fat as a fuel source.

How is it taken?

Mounjaro is administered as a weekly injection under the skin, typically in the abdomen, upper leg, or upper arm.

What are the benefits?

  • It is highly effective for weight loss, with many patients losing over 25% of their body weight.

  • It causes less muscle loss compared to fasting diets (30% loss versus 50-66% loss).

  • It has been shown to improve cardiovascular health and protect against kidney disease.

What are the common side effects?

Like all medications, Mounjaro may cause side effects.

Common side effects can include:

  • Nausea

  • Diarrhoea

  • Vomiting

  • Constipation

  • Abdominal pain

  • Headache

Uncommon side effects may include:

  • Acute pancreatitis (recent studies have not shown an increased risk).

  • Gallstones (which can occur with other medications that induce rapid weight loss).

Who shouldn't take it?

Like all medications, Mounjaro may cause side effects.

  • A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

  • A diagnosis of gastroparesis.

  • Anyone with a history of an eating disorder.

Weight Loss Medication

Understanding Weight Loss Medication

Mounjaro and Foundayo are weight-loss medications that help regulate appetite, support fat burning, and manage blood sugar. It is suitable for people with obesity, certain health conditions, or Type 2 diabetes. Mounjaro can produce significant weight loss and may also benefit heart and kidney health. It may cause side effects and is not suitable for everyone.

What is Mounjaro?

Mounjaro (tirzepatide) is a prescription medication that combines two hormones, GLP-1 and GIP, which both play essential roles in regulating appetite and immune function.

Who is it for?

  • Patients with obesity or a BMI in the overweight range with a health complication.

  • Patients with Type 2 diabetes.

How does Mounjaro work?

  • It slows the rate at which food leaves the stomach, helping you feel full for a longer period.

  • It reduces 'food noise' or distractions related to hunger.

  • It encourages the body to utilise fat as a fuel source.

How is it taken?

Mounjaro is administered as a weekly injection under the skin, typically in the abdomen, upper leg, or upper arm.

What are the benefits?

  • It is highly effective for weight loss, with many patients losing over 25% of their body weight.

  • It causes less muscle loss compared to fasting diets (30% loss versus 50-66% loss).

  • It has been shown to improve cardiovascular health and protect against kidney disease.

What are the common side effects?

Like all medications, Mounjaro may cause side effects.

Common side effects can include:

  • Nausea

  • Diarrhoea

  • Vomiting

  • Constipation

  • Abdominal pain

  • Headache

Uncommon side effects may include:

  • Acute pancreatitis (recent studies have not shown an increased risk).

  • Gallstones (which can occur with other medications that induce rapid weight loss).

Who shouldn't take it?

Like all medications, Mounjaro may cause side effects.

  • A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

  • A diagnosis of gastroparesis.

  • Anyone with a history of an eating disorder.

Weight Loss Medication

Understanding Weight Loss Medication

Mounjaro and Foundayo are weight-loss medications that help regulate appetite, support fat burning, and manage blood sugar. It is suitable for people with obesity, certain health conditions, or Type 2 diabetes. Mounjaro can produce significant weight loss and may also benefit heart and kidney health. It may cause side effects and is not suitable for everyone.

What is Mounjaro?

Mounjaro (tirzepatide) is a prescription medication that combines two hormones, GLP-1 and GIP, which both play essential roles in regulating appetite and immune function.

Who is it for?

  • Patients with obesity or a BMI in the overweight range with a health complication.

  • Patients with Type 2 diabetes.

How does Mounjaro work?

  • It slows the rate at which food leaves the stomach, helping you feel full for a longer period.

  • It reduces 'food noise' or distractions related to hunger.

  • It encourages the body to utilise fat as a fuel source.

How is it taken?

Mounjaro is administered as a weekly injection under the skin, typically in the abdomen, upper leg, or upper arm.

What are the benefits?

  • It is highly effective for weight loss, with many patients losing over 25% of their body weight.

  • It causes less muscle loss compared to fasting diets (30% loss versus 50-66% loss).

  • It has been shown to improve cardiovascular health and protect against kidney disease.

What are the common side effects?

Like all medications, Mounjaro may cause side effects.

Common side effects can include:

  • Nausea

  • Diarrhoea

  • Vomiting

  • Constipation

  • Abdominal pain

  • Headache

Uncommon side effects may include:

  • Acute pancreatitis (recent studies have not shown an increased risk).

  • Gallstones (which can occur with other medications that induce rapid weight loss).

Who shouldn't take it?

Like all medications, Mounjaro may cause side effects.

  • A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

  • A diagnosis of gastroparesis.

  • Anyone with a history of an eating disorder.

Treatment comparison

Foundayo vs Mounjaro: what’s the difference?

Both treatments can support clinically supervised weight loss, but they work in slightly different ways. The right choice depends on your medical history, goals, side-effect profile and clinician assessment.

Foundayo (Tablet)

Contains orforglipron, an oral GLP-1-like molecule. It helps regulate appetite and satiety signals, supporting reduced food intake alongside lifestyle changes.

Active ingredient: Orforglipron

Target: GLP‑1 pathway

Usually considered when weight-loss medication is clinically appropriate after assessment.

Mounjaro (Injection)

Contains tirzepatide, an injected peptide that acts on both the GIP and GLP‑1 pathways. This dual action can influence appetite, satiety and blood-sugar regulation.

Active ingredient: tirzepatide

Target: GIP and GLP‑1 pathways

May be discussed for weight management or Type 2 diabetes support when clinically suitable.

Treatment comparison

Foundayo vs Mounjaro: what’s the difference?

Both treatments can support clinically supervised weight loss, but they work in slightly different ways. The right choice depends on your medical history, goals, side-effect profile and clinician assessment.

Foundayo (Tablet)

Contains orforglipron, an oral GLP-1-like molecule. It helps regulate appetite and satiety signals, supporting reduced food intake alongside lifestyle changes.

Active ingredient: Orforglipron

Target: GLP‑1 pathway

Usually considered when weight-loss medication is clinically appropriate after assessment.

Mounjaro (Injection)

Contains tirzepatide, an injected peptide that acts on both the GIP and GLP‑1 pathways. This dual action can influence appetite, satiety and blood-sugar regulation.

Active ingredient: tirzepatide

Target: GIP and GLP‑1 pathways

May be discussed for weight management or Type 2 diabetes support when clinically suitable.

Treatment comparison

Foundayo vs Mounjaro: what’s the difference?

Both treatments can support clinically supervised weight loss, but they work in slightly different ways. The right choice depends on your medical history, goals, side-effect profile and clinician assessment.

Foundayo (Tablet)

Contains orforglipron, an oral GLP-1-like molecule. It helps regulate appetite and satiety signals, supporting reduced food intake alongside lifestyle changes.

Active ingredient: Orforglipron

Target: GLP‑1 pathway

Usually considered when weight-loss medication is clinically appropriate after assessment.

Mounjaro (Injection)

Contains tirzepatide, an injected peptide that acts on both the GIP and GLP‑1 pathways. This dual action can influence appetite, satiety and blood-sugar regulation.

Active ingredient: tirzepatide

Target: GIP and GLP‑1 pathways

May be discussed for weight management or Type 2 diabetes support when clinically suitable.

Treatment comparison

Foundayo vs Mounjaro: what’s the difference?

Both treatments can support clinically supervised weight loss, but they work in slightly different ways. The right choice depends on your medical history, goals, side-effect profile and clinician assessment.

Foundayo (Tablet)

Contains orforglipron, an oral GLP-1-like molecule. It helps regulate appetite and satiety signals, supporting reduced food intake alongside lifestyle changes.

Active ingredient: Orforglipron

Target: GLP‑1 pathway

Usually considered when weight-loss medication is clinically appropriate after assessment.

Mounjaro (Injection)

Contains tirzepatide, an injected peptide that acts on both the GIP and GLP‑1 pathways. This dual action can influence appetite, satiety and blood-sugar regulation.

Active ingredient: tirzepatide

Target: GIP and GLP‑1 pathways

May be discussed for weight management or Type 2 diabetes support when clinically suitable.

CLINICAL TRIAL RESULTS

Average weight loss over 72 weeks

Percentage reduction in body weight over time in the highest-dose treatment groups.

0%

5%

10%

15%

20%

Foundayo 12.4%

Mounjaro 20.9%

Foundayo

12.4% at week 72

Mounjaro

20.9% at week 72

Week 0

Week 16

Week 32

Week 48

Week 72

Foundayo (orforglipron)

Mounjaro (tirzepatide)

Figures are trial averages and do not predict individual results. Sources: ATTAIN-1 (orforglipron, 72 weeks) and SURMOUNT-1 (tirzepatide, 72 weeks).

Approaches to Effective Weight Management

At thrive healthcare, we support patients who continue to struggle with weight management despite making meaningful lifestyle changes. During a consultation, our clinicians can discuss the full range of evidence‑based medical options that may be appropriate for you, including how these treatments work and what to expect. We provide a fully managed service, including monitoring and follow‑up, and we coordinate any necessary adjustments to your treatment plan without directing you back to your GP for issues related to your care with us.

Approaches to Effective Weight Management

At thrive healthcare, we support patients who continue to struggle with weight management despite making meaningful lifestyle changes. During a consultation, our clinicians can discuss the full range of evidence‑based medical options that may be appropriate for you, including how these treatments work and what to expect. We provide a fully managed service, including monitoring and follow‑up, and we coordinate any necessary adjustments to your treatment plan without directing you back to your GP for issues related to your care with us.

Approaches to Effective Weight Management

At thrive healthcare, we support patients who continue to struggle with weight management despite making meaningful lifestyle changes. During a consultation, our clinicians can discuss the full range of evidence‑based medical options that may be appropriate for you, including how these treatments work and what to expect. We provide a fully managed service, including monitoring and follow‑up, and we coordinate any necessary adjustments to your treatment plan without directing you back to your GP for issues related to your care with us.

Find Out if Mounjaro Is Right for You

Book a consultation to explore whether Mounjaro could support your weight loss or Type 2 diabetes management.

Find Out if Mounjaro Is Right for You

Book a consultation to explore whether Mounjaro could support your weight loss or Type 2 diabetes management.

Find Out if Mounjaro Is Right for You

Book a consultation to explore whether Mounjaro could support your weight loss or Type 2 diabetes management.

Find Out if Mounjaro Is Right for You

Book a consultation to explore whether Mounjaro could support your weight loss or Type 2 diabetes management.

Find Out if Mounjaro Is Right for You

Book a consultation to explore whether Mounjaro could support your weight loss or Type 2 diabetes management.